Companies: 10,795·Total market cap: $144.5T
MorphoSys AG

MorphoSys AG

MORNASDAQHealthcare
$18.96
+$0.45(+2.43%)
Market Cap$2.9B
P/E Ratio
52W High$19.5
52W Low$4.185

MorphoSys AG(MOR)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

mor · 股价预测 · 10 位分析师(近3月)· FMP · 更新于 2025年10月6日

分析师评级与共识

基于过去 3 个月内 10 位华尔街分析师

SellBuy

Buy

10 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
5
Sell
0
Strong Sell
0
合计: 10 · 买入占比: 50.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $18.96

MorphoSys AG(MOR)的分析师共识为 Buy,基于过去 3 个月内 10 位华尔街分析师的评级。MOR 的 12 个月平均目标价为 $0.00,相对当前价 $18.96 代表 +0.0% 的潜在上行空间。

短期股价预测

⚠️ 短期模型暂不可用——近期成交量过低,信号不可靠。

长期股价预测

⚠️ 长期模型暂不可用——成交量过低,信号不可靠。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

71%29%0%
10Buy
4Neutral
0Sell
RSI (14)63.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MOR · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$18.96NEUTRAL
MA 10$18.80BUY
MA 20$18.66BUY
MA 50$18.46BUY
MA 100$18.29BUY
MA 200$0.00NEUTRAL
Current $MOR · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$18.92BUY
EMA 10$18.83BUY
EMA 20$18.71BUY
EMA 50$18.51BUY
EMA 100$18.28BUY
EMA 200$0.00NEUTRAL
Current $MOR · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Wells Fargo2024-03-14
Downgrade ↓
OverweightEqual Weight
Wells Fargo2024-02-05
Maintains
OverweightOverweight
Morgan Stanley2024-01-19
Downgrade ↓
OverweightEqual Weight
Morgan Stanley2024-01-16
Downgrade ↓
OverweightEqual Weight
Wells Fargo2023-12-15
Maintains
OverweightOverweight
JP Morgan2023-12-05
Maintains
OverweightOverweight
Goldman Sachs2023-11-22
Maintains
NeutralNeutral
JMP Securities2023-11-21
Maintains
Market OutperformMarket Outperform
Morgan Stanley2023-10-13
Upgrade ↑
UnderweightOverweight
Morgan Stanley2023-10-12
Upgrade ↑
UnderweightOverweight

Wall Street analysts have recently issued updated ratings on MorphoSys AG (MOR) stock. Of the recent 40 rating actions, 10 were upgrades and 15 were downgrades. 10 analysts currently cover MOR.

分析师推荐趋势

Buy ratings202
Hold ratings01↑ +1
Sell ratings00

MOR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$220M

↓ 46.8% YoY

Revenue Next Year

$324M

↑ 47.2% YoY

EPS This Year

$-2.38

EPS Next Year

$-1.37

↓ 42.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MOR EPS of $-2.38 for the current fiscal year, based on estimates from 4 analysts. The MOR revenue forecast is $220M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MOR 股价预测由两类独立数据源支撑:来自 10 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MOR 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

MorphoSys AG 在 NASDAQ 上市,代码 MOR。MOR 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MOR 预测 · 8 个问题

根据 10 位华尔街分析师,MOR 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $18.96,隐含约 +0.0% 的上行空间。

MOR 目标价MOR 分析师目标价MOR 12个月目标价目标价 MOR

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.